Skip to main content

3 Result(s)

within Article Remove this filter Barbara K. Dunn Remove this filter English Remove this filter Oncology Remove this filter

and

  1. Article

    Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug

    Tamoxifen is a drug that has been in worldwide use for the treatment of estrogen receptor (ER)-positive breast cancer for over 30 years; it has been used in both the metastatic and adjuvant settings. Tamoxifen...

    Matteo Lazzeroni, Davide Serrano, Barbara K Dunn… in Breast Cancer Research (2012)

    Download PDF (711 KB) View Article

  2. No Access

    Article

    Update on Phase I/II Breast Cancer Prevention Trials

    The greatest success in breast cancer prevention has been with two agents, tamoxifen and raloxifene, both of which are approved by the US Food and Drug Administration (FDA) for the risk reduction of invasive b...

    Brandy M. Heckman-Stoddard, Kathleen A. Foster… in Current Breast Cancer Reports (2011)

  3. No Access

    Article

    Health disparities in breast cancer: biology meets socioeconomic status

    Breast cancer is the most common cancer in women worldwide, accounting for just over 1 million new cases annually. Population-based statistics show that globally, when compared to whites, women of African ance...

    Barbara K. Dunn, Tanya Agurs-Collins, Doris Browne… in Breast Cancer Research and Treatment (2010)